For relief of occasional constipation (irregularity). Correctol® 50 Plus™ Laxative will produce a bowel movement in 6 to 12 hours.

Directions:    Adults and children 12 years of age and older:   Take 1 or 2 tablets in a single dose once daily at bedtime. Children 6 to under 12 years of age: Take 1 tablet daily. Children under 6 years of age: consult a doctor.

:   Do not give to children under 6 years of age, unless directed by a doctor. Do not use laxative products when abdominal pain, nausea or vomiting are present unless directed by a doctor. If you have noticed a sudden change in bowel habits that persists over a period of 2 weeks, consult a doctor before using a laxative. Laxative products should not be used for a period longer than 1 week unless directed by a doctor. Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Discontinue use and consult your doctor. All stimulant laxatives may cause abdominal discomfort, faintness and cramps. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product. Keep this and all drugs out of the reach of children. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.

Drug Interaction Precaution:   Do not take this product if you are presently taking mineral oil, unless directed by a doctor.

Store between 15° and 25°C (59° and 77°F). Protect from excessive moisture.

Active Ingredients (Per tablet): Sennosides (20 mg) and Docusate Sodium (100 mg).

Inactive Ingredients:   Carnauba Wax, Croscarmellose Sodium, D&C Red No. 27 Aluminum Lake, Hydroxypropyl Methylcellulose, Lactose, Magnesium Stearate, Polydextrose, Polyethylene Glycol, Povidone, Silicon Dioxide, Sodium Benzoate, Titanium Dioxide, Triacetin.


NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.